Fortress Biotech Inc.

FBIOP | NASDAQ

Price Alert Chart Builder DCF Calculator

$17.15

-$0.12 (-0.69%)

At close: Sep 22, 2026, 4:00 PM ET

$17.10

-$0.05 (-0.29%)

After-hours: Sep 22, 2026, 4:10 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $135.95M

Enterprise Value $130.79M

Beta 1.21

Average Volume N/A

Shares Outstanding (Diluted) 29.82M

Shares Change YoY 62.82%

Institutional Ownership N/A

Exchange N/A

ISIN N/A

Price Performance

Price Change 1M N/A

Price Change 3M N/A

Price Change 6M N/A

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) -13.1%

1Y CAGR (ann.) 91.7%

5Y CAGR (ann.) -2.1%

All-Time CAGR 4.4%

Valuation

PE Ratio -14.89

Forward PE N/A

PEG Ratio 0.00

Forward PEG -0.01

PS Ratio 2.29

Forward PS 1.20

PB Ratio 3.10

P/FCF Ratio -1.70

P/Adj. FCF Ratio -1.14

P/OCF Ratio 4.34

EV/Sales 2.21

EV/EBIT -1.71

EV/EBITDA -1.82

EV/FCF -1.63

Earnings Yield -6.7%

FCF Yield -58.9%

Adj. FCF Yield -87.8%

Financial Health

Net Cash $20.61M

Total Debt $69.22M

Cash & Short-Term Investments $74.39M

Total Assets $159.9M

Current Ratio 3.96

Quick Ratio 3.83

Debt / Equity Ratio 0.39

Debt / EBITDA -0.96

Debt / FCF -0.86

OCF / Debt -1.16

Interest Coverage -3.27

Altman Z-Score -5.61

Piotroski F-Score 6

Margins & Profitability

Gross Profit Margin 62.5%

Operating Profit Margin -176.6%

EBITDA Margin 233.4%

Net Profit Margin 163.3%

FCF Margin -135.1%

Adj. FCF Margin -201.3%

SBC / Revenue 8.3%

SBC Impact (per share) -49.0%

Returns

Return on Assets 35.3%

Return on Equity 103.5%

Return on Invested Capital -10.8%

Return on Capital Employed -11.5%

Return on Tangible Assets 38.4%

Historical Growth (CAGR)

Revenue CAGR 3Y -10.3%

Revenue CAGR 5Y 6.5%

Revenue CAGR 10Y 61.2%

EPS CAGR 3Y 111.3%

EPS CAGR 5Y 24.3%

EPS CAGR 10Y 22.2%

FCF CAGR 3Y 38.2%

FCF CAGR 5Y 9.8%

FCF CAGR 10Y -6.2%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Nov 15, 2026

EPS Estimate (next Q) -$0.27

EPS Growth Est (next Q) -345.4%

Revenue Est (next Q) $21.58M

Revenue Growth Est (next Q) 22.4%

Cash Flow

Operating Cash Flow $-80.09M

Free Cash Flow $-80.09M

Adj. Free Cash Flow $-119.36M

FCF Per Share $3.97

OCF Per Share $3.98

OCF/S Ratio 183.9%

Income Statement

Revenue $59.3M

Gross Profit $42.05M

Operating Income $-104.72M

EBITDA $-71.92M

Net Income $-14.73M

EPS (Diluted) -$1.16

Revenue / Employee N/A

Profit / Employee N/A

Employees N/A